tiprankstipranks
Trending News
More News >
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market

Skye Bioscience (SKYE) Income Statement

Compare
949 Followers

Skye Bioscience Income Statement

Last quarter (Q4 2025), Skye Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Skye Bioscience's net income was $-14.44M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -723.35K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 57.44M$ 30.19M$ 34.74M$ 18.31M$ 7.85M
Depreciation and Amortization
$ 723.35K$ 298.64K$ 124.25K$ 115.00K$ 34.13K
EBITDA
$ -57.44M$ -25.29M$ -36.62M$ -18.70M$ -7.72M
Operating Income
$ -58.16M$ -30.19M$ -34.74M$ -18.31M$ -7.85M
Other Income/Expenses
$ 2.24M$ 3.64M$ -2.91M$ -1.16M$ -672.37K
Pretax Income
$ -55.92M$ -26.56M$ -37.64M$ -19.47M$ -8.52M
Net Income
$ -55.92M$ -26.57M$ -37.64M$ -19.48M$ -8.52M
Per Share Metrics
Basic EPS
$ -1.41$ -0.73$ -5.37$ -8.77$ -5.00
Diluted EPS
$ -1.41$ -0.73$ -5.37$ -8.77$ -5.00
Weighted Average Shares Outstanding
39.66M 36.49M 7.01M 2.22M 1.63M
Weighted Average Shares Outstanding (Diluted)
39.66M 36.49M 7.01M 2.22M 1.63M
Currency in USD

Skye Bioscience Earnings and Revenue History